These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3066488

  • 1. Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.
    Ochoa EL, Medrano S, de Carlin MC, Dilonardo AM.
    Cell Mol Neurobiol; 1988 Sep; 8(3):325-31. PubMed ID: 3066488
    [Abstract] [Full Text] [Related]

  • 2. Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
    Ochoa EL, Li LA, Plummer A, McNamee MG.
    Mol Pharmacol; 1990 Dec; 38(6):863-71. PubMed ID: 2250665
    [Abstract] [Full Text] [Related]

  • 3. Structural requirements for the biological activity of thymopentin analogs.
    Heavner GA, Audhya T, Kroon D, Goldstein G.
    Arch Biochem Biophys; 1985 Oct; 242(1):248-55. PubMed ID: 2996431
    [Abstract] [Full Text] [Related]

  • 4. Thymopoietin to thymopentin: experimental studies.
    Goldstein G, Audhya TK.
    Surv Immunol Res; 1985 Oct; 4 Suppl 1():1-10. PubMed ID: 2994196
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junction.
    Quik M, Collier B, Audhya T, Goldstein G.
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1113-9. PubMed ID: 1967127
    [Abstract] [Full Text] [Related]

  • 7. Thymopoietin, a thymic polypeptide, regulates nicotinic alpha-bungarotoxin sites in chromaffin cells in culture.
    Quik M, Afar R, Geertsen S, Audhya T, Goldstein G, Trifaró JM.
    Mol Pharmacol; 1990 Jan; 37(1):90-7. PubMed ID: 1967819
    [Abstract] [Full Text] [Related]

  • 8. Thymopoietin, a thymic polypeptide, specifically interacts at neuronal nicotinic alpha-bungarotoxin receptors.
    Quik M, Afar R, Audhya T, Goldstein G.
    J Neurochem; 1989 Oct; 53(4):1320-3. PubMed ID: 2769271
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunomodulation with thymopentin: in vitro studies.
    Duchateau J, Bolla K.
    Med Oncol Tumor Pharmacother; 1989 Oct; 6(1):19-23. PubMed ID: 2657246
    [Abstract] [Full Text] [Related]

  • 12. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide.
    Verhaegen H, De Cock W, De Cree J, Goldstein G.
    J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790
    [Abstract] [Full Text] [Related]

  • 13. Thymopentin: stability considerations and potency by various routes of administration.
    Audhya TK, Goldstein G.
    Surv Immunol Res; 1985 Sep; 4 Suppl 1():17-23. PubMed ID: 3898289
    [Abstract] [Full Text] [Related]

  • 14. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study.
    Auteri A, Laghi Pasini F, Pasqui AL, Bilenchi R, Di Perri T.
    Boll Soc Ital Biol Sper; 1980 Feb 29; 56(4):312-5. PubMed ID: 7018515
    [No Abstract] [Full Text] [Related]

  • 15. Immunokinetics of a single dose of thymopoietin pentapeptide.
    Di Perri T, Laghi Pasini F, Auteri A.
    J Immunopharmacol; 1980 Feb 29; 2(4):567-72. PubMed ID: 7009760
    [Abstract] [Full Text] [Related]

  • 16. Thymopoietin and thymopentin enhance the levels of ACTH, beta-endorphin and beta-lipotropin from rat pituitary cells in vitro.
    Malaise MG, Hazee-Hagelstein MT, Reuter AM, Vrinds-Gevaert Y, Goldstein G, Franchimont P.
    Acta Endocrinol (Copenh); 1987 Aug 29; 115(4):455-60. PubMed ID: 2820173
    [Abstract] [Full Text] [Related]

  • 17. The effect of TP-5 and its analogs on skin grafts in mice.
    Szende B, Kisfaludy L, Lapis K, Dénes L, Szporny L, Nyéke O, Schön I, Hajós G, Ember J, Constantin M.
    J Immunopharmacol; 1985 Aug 29; 7(1):67-78. PubMed ID: 3891868
    [Abstract] [Full Text] [Related]

  • 18. The influence of new thymopoietin derivatives on the immune response of inbred mice.
    Rajnavölgyi E, Kulics J, Szilágyvári M, Kisfaludy L, Nyéki O, Schön I, Gergely J.
    Int J Immunopharmacol; 1986 Aug 29; 8(2):167-77. PubMed ID: 3519478
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological induced depression of E-rosette forming cells (RFC) of normal healthy subjects. Restoration by levamisole and thymopoietin pentapeptide.
    Laghi Pasini F, Auteri A, Ceccatelli L, Di Perri T.
    Boll Soc Ital Biol Sper; 1980 Feb 29; 56(4):316-22. PubMed ID: 7018516
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.